These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38863022)

  • 1. Swallowing characterization of adult-onset Niemann-Pick, type C1 patients.
    Solomon BI; Muñoz AM; Sinaii N; Mohamed H; Farhat NM; Alexander D; Do AD; Porter FD
    Orphanet J Rare Dis; 2024 Jun; 19(1):231. PubMed ID: 38863022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic expression of swallowing function in Niemann-Pick disease type C1.
    Solomon BI; Muñoz AM; Sinaii N; Farhat NM; Smith AC; Bianconi S; Dang Do A; Backman MC; Machielse L; Porter FD
    Orphanet J Rare Dis; 2022 Sep; 17(1):342. PubMed ID: 36064725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
    Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
    JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.
    Fecarotta S; Amitrano M; Romano A; Della Casa R; Bruschini D; Astarita L; Parenti G; Andria G
    Am J Med Genet A; 2011 Mar; 155A(3):540-7. PubMed ID: 21344635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Dysphagia and Longitudinal Changes in Swallowing Function in Adults with Niemann-Pick Disease Type C Treated with Miglustat.
    Lewis C; Keage M; Watanabe M; Schubiger D; Velakoulis D; Walterfang M; Vogel AP
    Dysphagia; 2021 Jun; 36(3):362-373. PubMed ID: 32562141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.
    Campbell K; Cawley NX; Luke R; Scott KEJ; Johnson N; Farhat NY; Alexander D; Wassif CA; Li W; Cologna SM; Berry-Kravis E; Do AD; Dale RK; Porter FD
    Biomark Res; 2023 Jan; 11(1):14. PubMed ID: 36721240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysphagia in Progressive Supranuclear Palsy.
    Clark HM; Stierwalt JAG; Tosakulwong N; Botha H; Ali F; Whitwell JL; Josephs KA
    Dysphagia; 2020 Aug; 35(4):667-676. PubMed ID: 31676923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1.
    Agrawal N; Farhat NY; Sinaii N; Do AD; Xiao C; Berry-Kravis E; Bianconi S; Masvekar R; Bielekova B; Solomon B; Porter FD
    Genet Med; 2023 Mar; 25(3):100349. PubMed ID: 36470574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term pharyngeal dysphagia after esophagectomy for esophageal cancer-an investigation using videofluoroscopic swallow studies.
    Yuen MTY; Tsang RK; Wong IYH; Chan DKK; Chan FSY; Law SYK
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30085000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swallowing function and medical diagnoses in infants suspected of Dysphagia.
    Newman LA; Keckley C; Petersen MC; Hamner A
    Pediatrics; 2001 Dec; 108(6):E106. PubMed ID: 11731633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otorhinolaryngological, audiovestibular and swallowing manifestations of patients with Niemann-Pick disease Type C.
    Senirli RT; Kuşçu O; Akyol U; Topçu M; Yiğit Ö; Aksoy S; Demir N
    Int J Pediatr Otorhinolaryngol; 2016 Jan; 80():1-4. PubMed ID: 26746602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal axonal degeneration in Niemann-Pick type C disease.
    Havla J; Moser M; Sztatecsny C; Lotz-Havla AS; Maier EM; Hizli B; Schinner R; Kümpfel T; Strupp M; Bremova-Ertl T; Schneider SA
    J Neurol; 2020 Jul; 267(7):2070-2082. PubMed ID: 32222928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial.
    Hastings C; Liu B; Hurst B; Cox GF; Hrynkow S
    Mol Genet Metab; 2022 Dec; 137(4):309-319. PubMed ID: 36279795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the maximal phonation test for the screening of dysphagia in stroke patients: a preliminary study.
    Lim JY; Yoo YH; Park CH; Joa KL; Jung HY
    Eur J Phys Rehabil Med; 2020 Feb; 56(1):41-46. PubMed ID: 31797658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1.
    Cawley NX; Giddens S; Farhat NM; Luke RA; Scott KEJ; Mohamed HO; Dang Do A; Berry-Kravis E; Cologna SM; Liu F; Porter FD
    Mol Genet Metab; 2023 Nov; 140(3):107656. PubMed ID: 37517328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial.
    Sharma R; Hastings C; Staretz-Chacham O; Raiman J; Paucar M; Spiegel R; Murray B; Hurst B; Liu B; Kjems L; Hrynkow S
    Mol Genet Metab Rep; 2023 Sep; 36():100988. PubMed ID: 37670901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory phenotype of Niemann-Pick disease, type C1.
    King KA; Gordon-Salant S; Yanjanin N; Zalewski C; Houser A; Porter FD; Brewer CC
    Ear Hear; 2014; 35(1):110-7. PubMed ID: 24225652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the natural history of patients who aspirate.
    Bock JM; Varadarajan V; Brawley MC; Blumin JH
    Laryngoscope; 2017 Dec; 127 Suppl 8(Suppl 8):S1-S10. PubMed ID: 28884823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol O-Acyltransferase 1 (
    Farhat NY; Alexander D; McKee K; Iben J; Rodriguez-Gil JL; Wassif CA; Cawley NX; Balch WE; Porter FD
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease.
    Völkner C; Liedtke M; Untucht R; Hermann A; Frech MJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.